INS and metabolic syndrome: Notably, all of the three genes are expressed in the liver and are reported to be associated with metabolic phenotypes including impairment of insulin secretion21, lipid profiles22, 23, risk of type 2 diabetes mellitus24 and cardiovascular diseases25 and metabolic syndrome pathway26.